Enveric Biosciences Inc

-0.03 (-11.65%)
Dividends, Debt Financing / Related, Divestitures / Spin-offs

Enveric Biosciences Announces Plans To Spin-Off And Dividend Its Cannabinoid Pipeline To Shareholders

Published: 05/11/2022 11:45 GMT
Enveric Biosciences Inc (ENVB) - Enveric Biosciences Announces Plans to Spin-off and Dividend Its Cannabinoid Pipeline to Shareholders.
Enveric Biosciences - Plans to Transfer and Spin-off Cannabinoid Clinical Development Pipeline Assets to a Unit, Acanna Therapeutics.
Enveric Biosciences Inc - Plans to Spin-off Its Cannabinoid Clinical Development Pipeline Assets by Way of Dividend to Enveric Shareholders.
Enveric Biosciences Inc - Spin-off Transaction Would Result in Two Standalone Public Companies.
Enveric Biosciences Inc - Acanna Has Secured an Initial $1mm From an Investor in a Series a Convertible Preferred Stock and Warrant Financing.
Enveric Biosciences Inc - Acanna Will, Subject to Certain Other Conditions, Receive an Additional $4mm Upon Completion of Spin-off.